For over 22 years pancreatica.org has provided current, credible, and comprehensive information to those in need.
Cancer Patient’s Alliance is a 501(c)(3) non-profit organization. All donations are tax-deductible.
94% of all revenue goes towards our programs, with only 6% towards MANAGEMENT AND GENERAL EXPENSES.
The FOLFIRINOX chemotherapy regimen for the treatment of advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) is a 4-drug combination therapy consisting of leucovorin calcium (folinic acid), fluorouracil (also known as 5-FU), irinotecan hydrochloride, and Oxaliplatin.
Use of this regimen emerged in 2010, and reached critical attention in the May 12, 2011 issue of the New England Journal of Medicine authored by Thierry Conroy, et al. which demonstrated that patients with advanced pancreatic cancer treated with FOLFIRINOX gained a survival advantage of about four months over those patients treated with gemcitabine alone (11.1 months compared to 6.8 months; P ≤ 0.001). The NCCN eventually recommended the FOLFIRINOX regimen as first line treatment for advanced pancreatic cancer.
The survival advantage does come with a price however, in that the side effects of the drugs can be severe. Subsequent research has proceeded with verification of efficacy, but with attempts and reducing or modifying this regimen to try to reduce the harsh side-effect profile.
In the Pancreatica Blog we have addressed this topic and these issues a number of times including Here, Here, Here, and Here.
Cancer Patients Alliance is a 501(c)(3) non-profit. Initiatives include, ToFightCancer.com and Pancreatica.org. All Donations are tax-deductible. Pancreatic cancer is the least funded cancer in terms of research.
Despite causing enormous mortality, pancreatic cancer receives (on a mortality basis) much less funding for research than most of the other major cancers. Currently, there is no molecular marker or genetic screening tool to aid in the earlier diagnosis or screening of pancreatic cancer. Treatment results would improve significantly if this cancer could be diagnosed at an earlier stage.
Choose a walk, run, or any other activity that you like and work to raise donations leading up to your Event! Simply set up your participation page and we will be in touch!
Already registered for your next Race? Dedicate your participation to Pancreatic Cancer. Simply set up your participation page and together we will work towards our shared mission!
Creating a Facebook Fundraiser is easy: Click the Link below and Facebook will take you through the steps! Dedicate your Birthday or another important date to honor a loved one.
Join us on Social Media !
Participate in #GivingTuesday for Pancreatic Cancer on December 3rd 2019!!
Click Here to Add a Calendar Reminder!
HONOR A LOVED ONE
BY SHARING YOUR STORY
You can honor your loved one by sharing your story with us. Whether it’s your personal story, honoring a friend or relative’s journey, or why you support the cause, we want to hear from you!
Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to help fight pancreatic cancer!
AmazonSmile is the same Amazon you know. Same products, same prices, same service. Simply use our Link to start shopping!
Pancreatic cancer is the most aggressive of the major cancers, has the highest mortality rate, and is the LEAST funded.
CLICK HERE TO MAKE A TAX-DEDUCTIBLE DONATION !
Call us at: 831-372-0900 or Email: participate@tofightcancer.com
Our mission is to promote awareness, increase education, and further pancreatic cancer research, specifically research aimed at early diagnosis.
Studies show that death rates for pancreatic cancer are increasing while for most other cancers they are declining, we need change !
Early diagnosis is key:
Survival increases dramatically if patients are diagnosed in time for surgery!
For medical information Click Here for our sister site Pancreatica.org
Pancreatica.org is a top-rated internet resource containing unique educational resources for patients, their caregivers, physicians and researchers, that displays an impressive concentration of scientific articles.
Currently, no standard marker exists to diagnose the disease in early stages. Our aim is to support the development of a marker for early diagnosis. If the disease is found even a year earlier, outcomes will begin to improve. LEARN MORE
Currently, only about 15% of those diagnosed with pancreatic cancer are eligible for potentially curative surgery. We need to find the disease earlier!
We are dedicated to promoting awareness, increasing education, and furthering pancreatic cancer research.
Pancreatic Cancer Blog – Commentary on Articles and AbstractsHere is where we take complex medical articles and break them down into language you and I
Pancreatic Cancer Blog – Commentary on Articles and AbstractsHere is where we take complex medical articles and break them down into language you and I
Pancreatic Cancer Blog – Commentary on Articles and AbstractsHere is where we take complex medical articles and break them down into language you and I
This study is basically looking at whether aspirin can make a chemotherapy drug called gemcitabine work better for pancreatic cancer. You’ve probably heard of aspirin; it’s the stuff you take for a headache or fever.
Cancer Patients Alliance is a 501(c)(3) non-profit. Initiatives include, ToFightCancer.com and Pancreatica.org. All Donations are tax-deductible. Pancreatic cancer is the least funded cancer in terms of research.
Despite causing enormous mortality, pancreatic cancer receives (on a mortality basis) much less funding for research than most of the other major cancers. Currently, there is no molecular marker or genetic screening tool to aid in the earlier diagnosis or screening of pancreatic cancer. Treatment results would improve significantly if this cancer could be diagnosed at an earlier stage.
© 2024 Pancreatica. All rights reserved | Privacy Policy
312 Fountain Avenue, Pacific Grove, California 93950 | Phone: (831) 658-0600 | Fax: (831) 658-0518 | participate@tofightcancer.com
